Dr. Gray is an experienced board member and scientist with a background in pharmacology research in tumor biology, including the impact of therapeutics on cardiac membranes. She has served on the board of biotechnology companies focused on new drug development in women’s health, CNS therapies and infectious disease. . Dr. Gray holds a PhD in Pharmacology from the University of Vermont. She completed her postdoctoral work at Northwestern University Medical School and at the Yale University School of Medicine.